小智港股覆盤 | 3月25日
今日，港股三大指數集體下跌。截止收盤，恆生指數大跌2.47%，報21404點。國企指數大跌3.24%，報7283點。恆生科技指數大跌4.98%，報4379點。市場約500只個股上漲，1265只個股下跌。成交額突破1475.69億港幣，和昨天同期相比下跌1.59%。南下資金淨流出32.49億港幣。
盤面上，專業服務板塊活躍。中安控股集團漲超16%；中國卓銀漲超6%；烯石電車新材料漲超5%；今海國際漲超1%。中安控股集團發佈2021年業績，股東應佔溢利148.8萬新加坡元，同比增加541.38%。
互聯網醫療板塊暴跌。醫脈通跌超24%；醫渡科技跌超11%；平安好醫生跌超10%；阿裏健康跌超9%。醫脈通去年股東應佔溢利4061.6萬元，同比減少52.3%；醫渡科技獲三名董事增持共29.89萬股；裏昂下調平安好醫生目標價至18.5元，評級「跑輸大市」。
航空貨運板塊全線走低。京東物流跌超13%；中通快遞-SW、健升物流中國等多股跌超6%；先豐服務集團跌超5%；駿高控股跌超4%。京東物流折讓近10%配股淨籌逾31億元，另向京東配股淨籌逾6.9億美元；中通快遞-SW將於4月22日派發特別股息每股0.25美元；先豐服務集團3月30日舉行董事會會議審批年度業績。
醫療設備板塊暴跌。沛嘉醫療-B跌超14%；時代天使跌超13%；威高股份、啓明醫療-B、愛康醫療等多股跌超10%。沛嘉醫療-B將於3月31日舉行董事會會議以審批年度業績；時代天使發佈2021年業績，股東應佔利潤約2.86億元，同比增長89.69%，特別末期股息每股1.22港元；威高股份延遲刊發2021年度經審覈綜合全年業績；啓明醫療-B3月31日舉行董事會會議審批年度業績；愛康醫療發佈2021年度業績，股東應佔溢利9261.9萬元，同比減少70.5%。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
